Table 12: LDL-C Percent Change from Baseline 1 LS Means are least square means adjusted for baseline LDL-C HeFH in Pediatric Patients In a double-blind, randomized, multicenter, placebo-controlled, 12-week study, 176 (97 male and 79 female) pediatric patients with HeFH were randomized to rosuvastatin 5 mg, 10 mg or 20 mg or placebo daily
The connection between tirzepatide, UTIs, and urinary health A common concern is whether tirzepatide increases your risk of urinary tract infections
That behavioral validation matters when interpreting study results
[1] All current GLP-1 therapy relies on established injectable formulations such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), which have extensive clinical evidence supporting their efficacy and safety
Hsieh, R